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Background: Intracardiac thrombus is a common cause of cardiogenic cerebral ischaemia. Stroke
recurrence is high, but thrombus detection with therapeutic intervention can reduce the risk. Accurate
detection requires transoesophageal echocardiography (TOE), which is semi-invasive and costly.
Objective: To identify risk factors for cardiac thrombus, enabling selection of patients for TOE and
initiation of measures to prevent the formation of cardiac thrombus.
Methods: 151 consecutive patients with ischaemic stroke or transient ischaemic attacks (mean age 62
years) underwent TOE for intracardiac thrombus detection within one week of a qualifying event.
Results: Intracardiac thrombus was found in 26% of the patients (70% in the left atrial appendage).
Multivariate analysis indicated the following clinical correlates: large stroke, odds ratio (OR) = 2.8 (95%
confidence interval, 1.2 to 6.4); symptomatic coronary artery disease, OR=3.0 (1.2 to 7.4); and ECG
evidence of ischaemia, OR=2.8 (1.1 to 7.7). Neither carotid stenosis .70%, nor stroke location
correlated with the presence of thrombus.
Conclusions: Clinical factors correlate with and appear to be risk factors for cardiac thrombus in patients
with recent cerebral ischaemia. These may be used to select appropriate patients for invasive and costly
TOE investigation, irrespective of the presence of significant carotid stenosis (>70%) or stroke location.
C
linical stroke registries show that 20–40% of strokes are
caused by cardiogenic emboli.1 2 These carry a signifi-
cantly worse prognosis than those of alternative
aetiology3 and also a higher recurrence risk.4 Intracardiac
thrombus is a common cardiac abnormality with a high
potential for embolisation to the cerebral vasculature.3 It
represents a definite indication for long term anticoagulation
to reduce the threat of recurrent stroke3 and possibly to
dissolve the thrombus.5
Transoesophageal echocardiography (TOE) has greatly
improved intracardiac thrombus detection, as thrombi are
usually located in the left atrium and left atrial appendage—
regions that are particularly well visualised,6 7 with a
sensitivity of 100% and a specificity of 99%.8 TOE is superior
to transthoracic echocardiography (TTE) for imaging the left
atrium and the left atrial appendage.6–11 However, concerns
have been raised about the cost–effectiveness and invasive-
ness of TOE.12
A hypercoagulable state may contribute to the aetiology of
cardiac thrombus. Patients with TOE findings of spontaneous
echocardiographic contrast (a marker of thromboembolism)
are in a relative hypercoagulable state.13 To our knowledge a
correlation between a hypercoagulable state and intracardiac
thrombus has not been investigated.
Our primary objective was to investigate whether the
presence of cardiac thrombus correlates with common
clinical variables after cerebral ischaemia, thereby refining
selection criteria for TOE. The secondary objective was to
investigate whether haematological or hypercoagulation
abnormalities are associated with intracardiac thrombus.
METHODS
In all, 164 consecutive patients satisfied the following entry
criteria:
N ability of non-comatose patient or surrogate to provide
informed consent;
N age more than18 years;
N first symptomatic ischaemic stroke or transient ischaemic
attack (TIA), with onset within the previous seven days.
All enrolled patients underwent stroke risk factor assess-
ment, ECG, and 24 hour Holter examination, haematological
assessment, and brain computed tomography (CT) or
magnetic resonance imaging (MRI). Carotid artery patency
was assessed in 87% of the cases, either by carotid duplex
ultrasound investigation or by magnetic resonance angio-
graphy (MRA). Patients without symptomatic coronary
artery disease underwent adenosine thallium myocardial
perfusion scanning to assess whether they had asymptomatic
coronary artery disease. The study was approved by the joint
committee on clinical investigation of Johns Hopkins
Hospital.
Multiplanar TOE was carried out in 151 of the 164 patients
within seven days of ischaemic stroke or TIA. Of the
remainder, there were nine refusals and TOE could not be
done on the initial admission in four. Two cardiologists
blinded to the patients’ clinical data reviewed examination
videotapes independently. In cases of discrepancy, results
were adjudicated independently by a third cardiologist.
Discrepancies in left ventricular thrombus status were
clarified by cross sectional echocardiography.
Symptomatic coronary artery disease was defined as a
confirmed history of myocardial infarction, angina, or
ischaemic cardiac failure. Stroke location was classified using
the Oxfordshire health study criteria.14 Large artery athero-
sclerotic source of thrombosis or embolism was assessed in
87% of patients by carotid ultrasound or MRA. A routine PA
x ray view of the chest was used to assess cardiomegaly. A
cardiothoracic ratio of >0.5 was considered significant. ST
elevation or depression of >1.5 mm with or without T wave
flattening, T wave inversion, or pathological Q wave on
Abbreviations: OCSP, Oxford Community Stroke Project; TOAST, The
Obesity Awareness and Solutions Trust; TOE, transoesophageal
echocardiography; TTE, transthoracic echocardiography
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routine 12-lead ECG at the time of admission were
considered signs of cardiac ischaemia. Paroxysmal or
continuous atrial fibrillation was documented on 24 hour
Holter examination done within seven days of stroke or TIA
symptom onset.
All blood tests were carried out within seven days of
cerebral ischaemia onset. All patients not anticoagulated
(oral or intravenous) were assessed for prothrombin time
(PT), activated partial thromboplastin time (aPTT), thrombin
time, diluted Russell viper venom test (dRVVT), protein C,
protein S, and antithrombin III activity. Sixty five patients
had assessments of activated protein C resistance, and 111
had assessment of anticardiolipin antibody activity (IgG, IgA,
and IgM classes). Patients without renal failure (plasma
creatinine (220 mmol/l) had measurement of fasting blood
homocysteine.
The association of stroke subtype with the presence of
intracardiac thrombus was explored using Fisher’s exact test.
Two tailed t tests compared mean ages of patients with and
without intracardiac thrombus. Univariate analysis included
Fisher’s exact test and estimation of odds ratios for each
stroke factor other than age. Finally, multiple logistic
regression analyses were carried out to obtain the odds ratio
(OR) adjusted for all other measured risk factors.
Statistical analyses were done using Instat version 2.0
(GraphPad, San Diego, California, USA) (two tailed t test,
Fisher’s exact test, and univariate odds ratio analysis) and
SPSS for Windows, version 10.0 (SPSS, Chicago, Illinois,
USA) (multivariate analysis and k analysis).
RESULTS
Intracardiac thrombus was identified in 26% of ischaemic
stroke/TIA patients (70% located in the left atrial appendage,
fig 1) with a k index of 0.91 (p,0.0001), indicating good
interobserver reliability. No demographic or risk factors
differentiated between those patients with and without
intracardiac thrombus (table 1). The majority of patients
with intracardiac thrombus (55%) had had a large stroke
(p=0.025) (table 2). There was no difference in clinical
stroke presentation between the 38 patients with thrombus
(five with total anterior and 15 with partial anterior
circulation infarction (TACI, PACI), 14 with lacunar infarc-
tion (LACI), and four with posterior circulation infarction
(POCI)) and the 88 patients without thrombus (seven with
TACI, 35 with PACI, 36 with LACI, and 10 with POCI). Nearly
25% of patients with small vessel disease in this study,
however, were found to have an intracardiac thrombus
(table 2). The majority of TIA patients (92%) lacked
echocardiographic evidence of intracardiac thrombus
(p=0.025). All haematological measurements were taken
at a median of five days from symptom onset in both
thrombus and non-thrombus patients. No haematological
variable or coagulation profile predicted the presence or
absence of intracardiac thrombus (tables 3 and 4).
Univariate testing (table 1, fig 2) suggests that, of the
common vascular risk factors, only coronary artery disease
might indicate the presence of intracardiac thrombus
(univariate odds ratio analysis, OR=2.1 (95% confidence
interval, 1.0 to 4.4); p=0.08). On multivariate analysis, the
adjusted OR for coronary artery disease became highly
significant (OR=3.0 (1.2 to 7.4); p=0.017) (fig 2). The
relation between radiological large stroke and intracardiac
thrombus was evident on univariate odds ratio analysis
(OR=2.2 (1.1 to 4.7)), persisting on multivariate analysis
(adjusted OR=2.8 (1.2 to 6.4)) (fig 2).
Of the cardiac variables, univariate analysis suggested that
only atrial fibrillation on ECG/Holter (OR=2.7 (1.1 to 6.5))
and left ventricular systolic dysfunction manifested by wall
motion abnormality on TOE (OR=3.4 (1.7 to 7.1)) were
correlated with intracardiac thrombus (fig 3). Multivariate
analysis showed that ischaemia on ECG (adjusted OR=2.8
(1.1 to 7.7) and systolic left ventricular dysfunction (adjusted
OR=3.9, 95% CI 1.5–10.5) were correlated with detection of
intracardiac thrombus on TOE.
DISCUSSION
In this prospective study, 70% of all thrombi were located in
the left atrial appendage. Using multivariate analysis, clinical
predictors independently associated with thrombus detection
included radiological large stroke, coronary artery disease,
and ECG evidence of ischaemia. On TOE, left ventricular
systolic dysfunction was associated with the presence of a
thrombus. Using the OCSP criteria, intracardiac thrombus
was not associated with any stroke subtype, nor did the
presence of significant carotid stenosis exclude this finding.
No haematological or coagulation variable significantly
Table 1 Demographics and risk factors of 151 patients
with stroke or transient ischaemic attack who underwent






n = 111 p Value*
Age (years) (mean (SD)) 63 (12.8) 62 (12.7) 0.7
Male sex 17 (42%) 56 (50%) 0.46
Black race 28 (70%) 70 (63%) 0.56
Hypertension 30 (75%) 82 (74%) 1.0
Diabetes 10 (25%) 34 (31%) 0.55
Hypercholesterolaemia 15 (37%) 44 (40%) 0.85
Smoking 25 (62%) 71 (64%) 1.0
Alcohol use 15 (37%) 38 (34%) 0.7
Carotid stenosis >70% 4/35 (11%) 23/96 (24%) 0.15
PVD 6 (15%) 23 (21%) 0.49
History of CAD 17 (42%) 30 (27%) 0.08
Atrial fibrillation 11 (27%) 15 (14%) 0.04
*Two tailed t test or Fisher’s exact test.
CAD, coronary artery disease; PVD, peripheral vascular disease.






(n = 111) p Value*
Large vessel 22 38 0.025
Small vessel 16 50 0.71
TIA 2 23 0.025
*Fisher’s exact test.
TIA, transient ischaemic attack.
Figure 1 Incidence and distribution of intracardiac thrombus detected
by transoesophageal echocardiography in patients with recent strokes or
transient ischaemic attacks.
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correlated with the presence of intracardiac thrombus in this
study.
Cardiac thrombus was detected in 26% of patients with
acute cerebral ischaemia, whereas previous TOE investiga-
tions enrolling smaller patient numbers have reported a
lower incidence of 3–22%.6 7 10 11 15 In this study, a more
accurate multiplanar TOE technique was used in all patients,
as opposed to monoplanar,7 biplanar,10 11 or both monoplanar
and biplanar TOE.6 15 Likewise, the sensitivity of detection of
intracardiac thrombus might have been heightened by a
systematic approach of investigating the left atrium, left
atrial appendage, and left ventricle for the presence of
thrombus in all stroke patients as part of the protocol,
without selection for age or lack of stroke aetiology. Indeed,
when stratified by age, the incidence of thrombus detection
in patients aged under 65 years was 9% (seven of 79) in
keeping with previously reported data. When the age cut off
is increased to 75 years (an age group often excluded from
TOE examination), the corresponding figure is 25% (31 of
122). Patients were not excluded because of stroke subtype
(for example, lacunar strokes) or TIA.
As in the present study, previous investigations have
confirmed that the left atrial appendage is the commonest
site for intracardiac thrombus.6 7 15 16 This may reflect the
lower blood flow velocity in the appendage than in the rest of
the left heart.16
Among clinical variables, intracardiac thrombus correlated
with coronary artery disease. This could be related to the
ventricular wall motion abnormalities observed in patients
with coronary artery disease with or without ischaemic
cardiomyopathy.17–19 In this study, left ventricular dysfunc-
tion was an independent predictor of intracardiac thrombus
on multivariate analysis, in keeping with this suggestion. An
additional causal relation probably reflects the higher
incidence of atrial fibrillation in patients with coronary artery
disease (52% in this study) than those without (27%,
p=0.005).
Intracardiac thrombus also correlated with large strokes on
CT/MRI—in agreement with recent studies showing that
patients with cardiogenic brain emboli have larger strokes
with worse prognosis than those without.3 This may also be
related to a significantly higher incidence of atrial fibrillation
in the thrombus group (27%) compared with the non-
thrombus group (13%) (p=0.045). This indicates a possible
need for TOE examination in patients with stroke and atrial
fibrillation, even if they are to be anticoagulated, as this
combination may place patients at higher risk of stroke
recurrence and indicates a possible requirement for more
intense anticoagulation. Previous studies have reported that
patients with atrial fibrillation have larger and more severe
strokes, which has been attributed to cerebral blood flow
reduction in the presence of this arrhythmia.20 The associa-
tion between atrial fibrillation and intracardiac thrombus
disappeared on multivariate analysis, when only ECG
evidence of ischaemia was predictive. This could reflect a
causative association between cardiac ischaemia and atrial
fibrillation.
In this study, 28% of patients with small vessel occlusive
disease, as defined by TOAST criteria, had TOE evidence of
intracardiac thrombus. Traditionally, small vessel occlusive
disease is attributed to hyaline arteriosclerosis of small
arterioles mediated by hypertension and diabetes, and such
patients are not pursued with TOE investigations. In a recent
biplanar TOE study of 22 patients with lacunar stroke no left
Table 3 Haematological profile of patients with stroke/TIA with and without intracardiac
thrombus
Variable Thrombus (n = 40) No thrombus (n = 111) p Value*
Haemoglobin (g/dl) 12.5 (1.7) 12.9 (1.8) 0.2
Packed cell volume (%) 37.4 (5.0) 38.4 (5.2) 0.3
Platelet count (k/mm3) 271.1 (89) 263.1 (81) 0.6
WBC count (/mm3) 8611 (2572) 7708 (2603) 0.06
25th centile 6375 6000
50th centile 8650 7600
75th centile 10 500 9100
ESR (mm/h) 44 (29) (n = 33) 42 (29) (n = 77) 0.8
Plasma viscosity (plas/sol) 1.89 (0.23) (n = 25) 1.81 (0.17) (n = 62) 0.1
Values are mean (SD).
*t Test.
ESR, erythrocyte sedimentation rate; TIA, transient ischaemic attack; WBC, white blood cell.
Table 4 Coagulation profile of patients with stroke/TIA with and without intracardiac
thrombus
Test (normal value) Thrombus (n = 40) No thrombus (n = 111) p Value*
PT (11.5–13.5 s) 12.4 (0.7) (n = 22) 12.2 (0.7) (n = 87) 0.2
aPTT (20.0–31.6 s) 26.7 (4.1) (n = 22) 25.4 (4.8) (n = 87) 0.2
dRVVT (29.3–42.8 s) 37.5 (15) (n = 17) 34.2 (9.3) (n = 52) 0.3
Fibrinogen (150–400 mg/dl) 499 (206) (n = 37) 457 (142) (n = 85) 0.2
Protein C deficiency (70–180%) 2/19 (10%) 2/62 (3%) 0.2
Protein S deficiency (65–140%) 0/19 (0) 3/62 (5%) 1.0
AT III deficiency (80–120%) 4/19 (21%) 6/62 (10%) 0.2
APC resistance (.2.1) 2/14 (14%) 5/51 (10%) 0.6
ACA IgG (,10 gpl/ml) 1/35 (3%) 1/76 (1%) 1.0
ACA IgA (,10 sdu) 1/35 (3%) 3/76 (4%) 1.0
ACA IgM (,10 mpl/ml) 2/35 (6%) 1/76 (1%) 0.2
Hyperhomocysteinaemia (5.1–13.9 mmol/l) 2/18 (11%) 8/51 (16%) 1.0
Values are mean (SD) or n (%).
*t Test or Fisher’s exact test.
ACA, anticardiolipin antibody; APC, activated protein C; aPTT, activated partial thromboplastin time; AT III,
antithrombin III; dRVVT, diluted Russel viper venom test; PT, prothrombin time; TIA, transient ischaemic attack.
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atrial thrombus was found, suggesting that TOE may be
superfluous in these patients.21 This discrepancy with the
current study is probably a result of the systematic use of
multiplanar TOE in a larger number of lacunar stroke
patients (n=50) and emphasises that patients presenting
with lacunar infarction should not necessarily be excluded
from TOE examination to rule out a cardiac source of
embolism.
TOE-determined left ventricular dysfunction was a sig-
nificant risk factor for intracardiac thrombus on both
univariate and multivariate analysis, in agreement with
other studies.22 23 Left ventricular dysfunction has been
described as a predictor of left atrial appendage thrombus
in non-stroke/TIA patients.24 As left ventricular function is
better assessed by TTE than by TOE,25 TTE may be used to
select those with left ventricular dysfunction, who may then
undergo the more invasive examination to assess the
presence of intracardiac thrombus.
Of the standard haematological studies, the total white
blood cell count was higher in the thrombus group and only
just escaped significance (p=0.06); this may be related to a
prothrombotic state associated with an occult infection.
Alternatively it may represent an acute phase reaction to
the stroke, which was larger in the thrombus group.26
However, other acute phase markers, such as ESR and the
fibrinogen level, were not increased in patients with cerebral
ischaemia who had intracardiac thrombus.
Indicators of a hypercoagulable state did not predict the
presence of intracardiac thrombus, although a non-signifi-
cant increase in protein C and antithrombin III deficiency
was seen in these patients. As most haemorheological
abnormalities are rare, the small number of patients is likely
to have reduced the statistical power required for assessment
of their contribution to the risk of intracardiac thrombus.
Additionally, the rate at which these abnormalities were
encountered in our study is unlikely to be related to an acute
phase or inflammatory response as the ESR and fibrinogen
values were similar in patients who had these coagulation
deficiencies and those who did not. Further studies on a
larger number of patients will be required to draw more
definitive conclusions in this regard.
Conclusions
Coronary artery disease, large stroke on CT/MRI, atrial
fibrillation, and ECG evidence of ischaemia are independent
risk factors for intracardiac thrombus in patients with recent
cerebral ischaemia. TOE evidence of left ventricular dysfunc-
tion is also a risk factor, though left ventricular dysfunction is
best assessed by TTE. We suggest, therefore, that patients
with recent cerebral ischaemia and the above factors, either
alone or in combination, should be selected for TOE
investigation, because of the 25% chance of intracardiac clot
detection. As stroke recurrence is high in these patients if
untreated, the use of these variables to focus TOE investiga-
tion on those with a high probability of harbouring an
intracardiac thrombus may improve outcome and the risk/
benefit ratio.
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